Using structural analysis and truncations of this fragment of human FAK as our starting point, we dissected the FAK-Akt1 interaction to define a short FAK-derived peptide that interrupts said interaction and demonstrated that this peptide inhibits cancer cell adhesion in vitro and in vivo and improves survival in a murine model of wound recurrence. This evidence concerns the gene AKT1 and cancer.